. . . . . . . . . . . "p(HGNC:KAT5) -> path(SDIS:\"Cisplatin resistance\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "We found that Tip60 is overexpressed in cisplatin-resistant cells. Knockdown of Tip60 expression rendered cells sensitive to cisplatin but not to oxaliplatin, vincristine, and etoposide. Tip60 expression is significantly correlated with cisplatin sensitivity in human lung cancer cell lines." . . "Selventa" . . . . "2014-07-03T14:33:21.140+02:00"^^ . . .